The Chemokine Decoy Receptor D6 Prevents Excessive Inflammation and Adverse Ventricular Remodeling After Myocardial Infarction
Authors:
- Constance AuvynetCAConstance Auvynet
- Lucie PoupelLPLucie Poupel
- José VilarJVJosé Vilar
- Edouard DumeauEDEdouard Dumeau
- Adèle RichartARAdèle Richart
- Alice RécaldeARAlice Récalde
- Yasmine ZouggariYZYasmine Zouggari
- Kiave Yune Ho Wang YinKYKiave Yune Ho Wang Yin
- Patrick BrunevalPBPatrick Bruneval
- Gilles RenaultGRGilles Renault
- Carmen MarchiolCMCarmen Marchiol
- 1 September 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (9) , 2206-2213
Abstract
Objective—: Leukocyte infiltration in ischemic areas is a hallmark of myocardial infarction, and overwhelming infiltration of innate immune cells has been shown to promote adverse remodeling and cardiac rupture. Recruitment of inflammatory cells in the ischemic heart depends highly on the family of CC-chemokines and their receptors. Here, we hypothesized that the chemokine decoy receptor D6, which specifically binds and scavenges inflammatory CC-chemokines, might limit inflammation and adverse cardiac remodeling after infarction. Methods and Results—: D6 was expressed in human and murine infarcted myocardium. In a murine model of myocardial infarction, D6 deficiency led to increased chemokine (C-C motif) ligand 2 and chemokine (C-C motif) ligand 3 levels in the ischemic heart. D6-deficient (D6 −/−) infarcts displayed increased infiltration of pathogenic neutrophils and Ly6Chi monocytes, associated with strong matrix metalloproteinase-9 and matrix metalloproteinase-2 activities in the ischemic heart. D6 −/− mice were cardiac rupture prone after myocardial infarction, and functional analysis revealed that D6 −/− hearts had features of adverse remodeling with left ventricle dilation and reduced ejection fraction. Bone marrow chimera experiments showed that leukocyte-borne D6 had no role in this setting, and that leukocyte-specific chemokine (C-C motif) receptor 2 deficiency rescued the adverse phenotype observed in D6 −/− mice. Conclusion—: We show for the first time that the chemokine decoy receptor D6 limits CC-chemokine–dependent pathogenic inflammation and is required for adequate cardiac remodeling after myocardial infarction.Keywords
This publication has 26 references indexed in Scilit:
- A New Monocyte Chemotactic Protein-1/Chemokine CC Motif Ligand-2 Competitor Limiting Neointima Formation and Myocardial Ischemia/Reperfusion Injury in MiceJACC, 2010
- Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularizationCardiovascular Research, 2010
- Impaired Infarct Healing in Atherosclerotic Mice With Ly-6ChiMonocytosisJACC, 2010
- CCL3 (MIP-1α) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic eventsJournal of Molecular and Cellular Cardiology, 2008
- The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functionsJournal of Experimental Medicine, 2007
- Tuning inflammation and immunity by chemokine sequestration: decoys and moreNature Reviews Immunology, 2006
- The Mechanistic Basis of Infarct HealingAntioxidants & Redox Signaling, 2006
- CC Chemokine Receptor-2 Deficiency Attenuates Oxidative Stress and Infarct Size Caused by Myocardial Ischemia-Reperfusion in MiceCirculation Journal, 2006
- Targeted Deletion of CC Chemokine Receptor 2 Attenuates Left Ventricular Remodeling after Experimental Myocardial InfarctionThe American Journal of Pathology, 2004
- Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureNature Medicine, 1999